Our findings not only establish PAX8‐AS1 as a biomarker for predicting chemoresistance but also validate the induction of ferroptosis as a precision strategy for enhancing chemosensitivity in ICC. The gene discussed is PAX8; the disease is intrahepatic cholangiocarcinoma.